Literature DB >> 18465771

Circumvention of regulatory CD4(+) T cell activity during cross-priming strongly enhances T cell-mediated immunity.

Antje Heit1, Friedemann Gebhardt, Katharina Lahl, Michael Neuenhahn, Frank Schmitz, Florian Anderl, Hermann Wagner, Tim Sparwasser, Dirk H Busch, Kathrin Kastenmüller.   

Abstract

Immunization with purified antigens is a safe and practical vaccination strategy but is generally unable to induce sustained CD8(+) T cell-mediated protection against intracellular pathogens. Most efforts to improve the CD8(+) T cell immunogenicity of these vaccines have focused on co-administration of adjuvant to support cross-presentation and dendritic cell maturation. In addition, it has been shown that CD4(+) T cell help during the priming phase contributes to the generation of protective CD8(+) memory T cells. In this report we demonstrate that the depletion of CD4(+) T cells paradoxically enhances long-lasting CD8-mediated protective immunity upon protein vaccination. Functional and genetic in vivo inactivation experiments attribute this enhancement primarily to MHC class II-restricted CD4(+) regulatory T cells (Treg), which appear to physiologically suppress the differentiation process towards long-living effector memory T cells. Since, in functional terms, this suppression by Treg largely exceeds the positive effects of conventional CD4(+) T cell help, even the absence of all CD4(+) T cells or lack of MHC class II-mediated interactions on priming dendritic cells result in enhanced CD8(+) T cell immunogenicity. These findings have important implications for the improvement of vaccines against intracellular pathogens or tumors, especially in patients with highly active Treg.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18465771     DOI: 10.1002/eji.200737966

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

Review 1.  Sizing up the key determinants of the CD8(+) T cell response.

Authors:  David C Tscharke; Nathan P Croft; Peter C Doherty; Nicole L La Gruta
Journal:  Nat Rev Immunol       Date:  2015-10-09       Impact factor: 53.106

2.  Dendritic cell targeted vaccines: Recent progresses and challenges.

Authors:  Pengfei Chen; Xinsheng Liu; Yuefeng Sun; Peng Zhou; Yonglu Wang; Yongguang Zhang
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

3.  FoxP3+ regulatory T cells essentially contribute to peripheral CD8+ T-cell tolerance induced by steady-state dendritic cells.

Authors:  Anita Schildknecht; Sabine Brauer; Corinne Brenner; Katharina Lahl; Hansjörg Schild; Tim Sparwasser; Hans Christian Probst; Maries van den Broek
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-15       Impact factor: 11.205

4.  CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis.

Authors:  Alice McNally; Geoffrey R Hill; Tim Sparwasser; Ranjeny Thomas; Raymond J Steptoe
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-18       Impact factor: 11.205

Review 5.  Dendritic cell-targeted vaccines--hope or hype?

Authors:  Wolfgang Kastenmüller; Kathrin Kastenmüller; Christian Kurts; Robert A Seder
Journal:  Nat Rev Immunol       Date:  2014-09-05       Impact factor: 53.106

6.  Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction.

Authors:  Wolfgang Kastenmuller; Georg Gasteiger; Naeha Subramanian; Tim Sparwasser; Dirk H Busch; Yasmine Belkaid; Ingo Drexler; Ronald N Germain
Journal:  J Immunol       Date:  2011-08-17       Impact factor: 5.422

7.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

Review 8.  Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications.

Authors:  Sébastien André; David F Tough; Sébastien Lacroix-Desmazes; Srini V Kaveri; Jagadeesh Bayry
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

9.  Foxp3+ Regulatory T-cells and IL-2: The Moirai of T-cell Fates?

Authors:  Georg Gasteiger; Wolfgang Kastenmuller
Journal:  Front Immunol       Date:  2012-07-12       Impact factor: 7.561

10.  Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella.

Authors:  Jerome S Harms; Marina A Durward; Diogo M Magnani; Gary A Splitter
Journal:  J Immune Based Ther Vaccines       Date:  2009-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.